Updated Jul 16, 2026 · Last SEC filing 2026-07-02
FENNEC PHARMACEUTICALS INC. (FENC) has filed 23 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-02. 5 Form 8-K material event filings were reported by FENC in the last 90 days. 4 Form 144 notices of proposed sale were filed for FENC stock. InsiderAlpha tracks every FENC SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Biological Products, (No Diagnostic Substances) (SIC 2836) |
|---|---|
| SEC CIK | 0001211583 |
| Form 4 filings (90d) | 23 |
|---|---|
| Form 8-K filings (90d) | 5 |
| Form 144 notices (90d) | 4 |
| Latest Form 4 filing | 2026-07-02 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Raykov Rosty | Insider | A — Grant or award | 2.8K | $0.00 | — | SEC | |
| Raykov Rosty | Insider | M — Option exercise | 15.6K | $2.45 | $38K | SEC | |
| Raykov Rosty | Insider | S — Open-market sale | 9.6K | $10.41 | $100K | SEC | |
| Evans Terry L | Chief Commercial Officer | A — Grant or award | 168 | $0.00 | — | SEC | |
| Hackman Jeffrey S. | Chief Executive Officer | A — Grant or award | 1.2K | $0.00 | — | SEC | |
| Sayad Pierre Sargis | Chief Medical Officer | A — Grant or award | 168 | $0.00 | — | SEC | |
| Cioffi Christiana Marie | Chief Strategy Officer | A — Grant or award | 156 | $0.00 | — | SEC | |
| Andrade Robert | CHIEF FINANCIAL OFFICER | A — Grant or award | 1.7K | $0.00 | — | SEC | |
| Raykov Rosty | Insider | M — Option exercise | 15.6K | $2.45 | $38K | SEC | |
| Raykov Rosty | Insider | S — Open-market sale | 9.7K | $9.62 | $94K | SEC | |
| Evans Terry L | Chief Commercial Officer | A — Grant or award | 168 | $0.00 | — | SEC | |
| Hackman Jeffrey S. | Chief Executive Officer | A — Grant or award | 1.2K | $0.00 | — | SEC | |
| Raykov Rosty | Insider | A — Grant or award | 2.8K | $0.00 | — | SEC | |
| Cioffi Christiana Marie | Chief Strategy Officer | A — Grant or award | 156 | $0.00 | — | SEC | |
| Andrade Robert | CHIEF FINANCIAL OFFICER | A — Grant or award | 1.7K | $0.00 | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for FENNEC PHARMACEUTICALS INC. (FENC). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Raykov Rosty | 12 | $493K |
| RALLIS CHRIS A | 4 | $303K |
| Hackman Jeffrey S. | 3 | — |
| Evans Terry L | 3 | — |
| Sayad Pierre Sargis | 3 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in FENC insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live FENC dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.